Aortic valve stenosis: from basic mechanisms to novel therapeutic targets
Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although
interventional treatment options have rapidly improved in recent years, symptomatic aortic …
interventional treatment options have rapidly improved in recent years, symptomatic aortic …
Calcification in aortic stenosis: the skeleton key
TA Pawade, DE Newby, MR Dweck - Journal of the American College of …, 2015 - jacc.org
Aortic stenosis is a common, potentially fatal condition that is set to become an increasing
public health burden. Once symptoms develop, there is an inexorable deterioration with a …
public health burden. Once symptoms develop, there is an inexorable deterioration with a …
Hormonal regulation of biomineralization
A Arnold, E Dennison, CS Kovacs… - Nature Reviews …, 2021 - nature.com
Biomineralization is the process by which organisms produce mineralized tissues. This
crucial process makes possible the rigidity and flexibility that the skeleton needs for …
crucial process makes possible the rigidity and flexibility that the skeleton needs for …
[HTML][HTML] The inhibitory roles of vitamin K in progression of vascular calcification
A Shioi, T Morioka, T Shoji, M Emoto - Nutrients, 2020 - mdpi.com
Vitamin K is a fat-soluble vitamin that is indispensable for the activation of vitamin K-
dependent proteins (VKDPs) and may be implicated in cardiovascular disease (CVD) …
dependent proteins (VKDPs) and may be implicated in cardiovascular disease (CVD) …
An update on vascular calcification and potential therapeutics
A Singh, S Tandon, C Tandon - Molecular Biology Reports, 2021 - Springer
Pathological calcification is a major cause of cardiovascular morbidities primarily in
population with chronic kidney disease (CKD), end stage renal diseases (ERSD) and …
population with chronic kidney disease (CKD), end stage renal diseases (ERSD) and …
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
J Lutz, K Jurk, H Schinzel - International journal of nephrology and …, 2017 - Taylor & Francis
Many patients with chronic kidney disease (CKD) receive anticoagulation or antiplatelet
therapy due to atrial fibrillation, coronary artery disease, thromboembolic disease, or …
therapy due to atrial fibrillation, coronary artery disease, thromboembolic disease, or …
[HTML][HTML] Vitamin K in chronic kidney disease
M Cozzolino, M Mangano, A Galassi, P Ciceri, P Messa… - Nutrients, 2019 - mdpi.com
Vitamin K is a composite term referring to a group of fat-soluble vitamins that function as a
cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which activates a number of vitamin …
cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which activates a number of vitamin …
[HTML][HTML] The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: a review
Warfarin has been utilized for decades as an effective anticoagulant in patients with a history
of strong risk factors for venous thromboembolism (VTE). Established adverse effects …
of strong risk factors for venous thromboembolism (VTE). Established adverse effects …
Coronary arterial calcification: a review of mechanisms, promoters and imaging
Coronary artery calcification (CAC) was once thought to be a passive, degenerative, and
quiescent development of disease. However, it has now been shown to be an active process …
quiescent development of disease. However, it has now been shown to be an active process …
[HTML][HTML] Role of vitamin K in chronic kidney disease: A focus on bone and cardiovascular health
F Bellone, M Cinquegrani, R Nicotera… - International Journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) is commonly associated with vitamin K deficiency. Some of
the serious complications of CKD are represented by cardiovascular disease (CVD) and …
the serious complications of CKD are represented by cardiovascular disease (CVD) and …